Literature DB >> 29184816

Type 1 diabetes: where are we in 2017?

Melanie Copenhaver1, Robert P Hoffman1.   

Abstract

Type 1 diabetes mellitus is a chronic state of insulin deficiency which results from destruction of beta cells by the immune system. The long term microvascular and macrovascular complications can be devastating. Since the discovery of insulin almost 100 years ago new medical therapies have improved the long-term survival for people with type 1 diabetes. Each year we come closer to discovering a cure but much work still needs to be done to eliminate this disease.

Entities:  

Keywords:  Type 1 diabetes; complications; insulin

Year:  2017        PMID: 29184816      PMCID: PMC5682377          DOI: 10.21037/tp.2017.09.09

Source DB:  PubMed          Journal:  Transl Pediatr        ISSN: 2224-4336


  42 in total

1.  Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

Authors:  David M Nathan; Patricia A Cleary; Jye-Yu C Backlund; Saul M Genuth; John M Lachin; Trevor J Orchard; Philip Raskin; Bernard Zinman
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

2.  Effects of insulin in relatives of patients with type 1 diabetes mellitus.

Authors: 
Journal:  N Engl J Med       Date:  2002-05-30       Impact factor: 91.245

3.  Immunosuppression with azathioprine and prednisone in recent-onset insulin-dependent diabetes mellitus.

Authors:  J Silverstein; N Maclaren; W Riley; R Spillar; D Radjenovic; S Johnson
Journal:  N Engl J Med       Date:  1988-09-08       Impact factor: 91.245

Review 4.  Novel diabetes autoantibodies and prediction of type 1 diabetes.

Authors:  Janet M Wenzlau; John C Hutton
Journal:  Curr Diab Rep       Date:  2013-10       Impact factor: 4.810

Review 5.  Trials in the prevention of type 1 diabetes: current and future.

Authors:  Diane K Wherrett
Journal:  Can J Diabetes       Date:  2014-08       Impact factor: 4.190

6.  Phase 3 Trial of Transplantation of Human Islets in Type 1 Diabetes Complicated by Severe Hypoglycemia.

Authors:  Bernhard J Hering; William R Clarke; Nancy D Bridges; Thomas L Eggerman; Rodolfo Alejandro; Melena D Bellin; Kathryn Chaloner; Christine W Czarniecki; Julia S Goldstein; Lawrence G Hunsicker; Dixon B Kaufman; Olle Korsgren; Christian P Larsen; Xunrong Luo; James F Markmann; Ali Naji; Jose Oberholzer; Andrew M Posselt; Michael R Rickels; Camillo Ricordi; Mark A Robien; Peter A Senior; A M James Shapiro; Peter G Stock; Nicole A Turgeon
Journal:  Diabetes Care       Date:  2016-04-18       Impact factor: 19.112

7.  Life expectancy of type 1 diabetic patients during 1997-2010: a national Australian registry-based cohort study.

Authors:  Lili Huo; Jessica L Harding; Anna Peeters; Jonathan E Shaw; Dianna J Magliano
Journal:  Diabetologia       Date:  2016-01-21       Impact factor: 10.122

8.  Sodium-glucose cotransporter 2 inhibition and glycemic control in type 1 diabetes: results of an 8-week open-label proof-of-concept trial.

Authors:  Bruce A Perkins; David Z I Cherney; Helen Partridge; Nima Soleymanlou; Holly Tschirhart; Bernard Zinman; Nora M Fagan; Stefan Kaspers; Hans-Juergen Woerle; Uli C Broedl; Odd-Erik Johansen
Journal:  Diabetes Care       Date:  2014-03-04       Impact factor: 19.112

9.  Continuous glucose monitoring and intensive treatment of type 1 diabetes.

Authors:  William V Tamborlane; Roy W Beck; Bruce W Bode; Bruce Buckingham; H Peter Chase; Robert Clemons; Rosanna Fiallo-Scharer; Larry A Fox; Lisa K Gilliam; Irl B Hirsch; Elbert S Huang; Craig Kollman; Aaron J Kowalski; Lori Laffel; Jean M Lawrence; Joyce Lee; Nelly Mauras; Michael O'Grady; Katrina J Ruedy; Michael Tansey; Eva Tsalikian; Stuart Weinzimer; Darrell M Wilson; Howard Wolpert; Tim Wysocki; Dongyuan Xing
Journal:  N Engl J Med       Date:  2008-09-08       Impact factor: 91.245

10.  Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes.

Authors:  Arthur T Sands; Brian P Zambrowicz; Julio Rosenstock; Pablo Lapuerta; Bruce W Bode; Satish K Garg; John B Buse; Phillip Banks; Rubina Heptulla; Marc Rendell; William T Cefalu; Paul Strumph
Journal:  Diabetes Care       Date:  2015-06-06       Impact factor: 19.112

View more
  9 in total

1.  Parallel Evaluation of Polyethylene Glycol Conformal Coating and Alginate Microencapsulation as Immunoisolation Strategies for Pancreatic Islet Transplantation.

Authors:  Teresa De Toni; Aaron A Stock; Floriane Devaux; Grisell C Gonzalez; Kailyn Nunez; Jessica C Rubanich; Susan A Safley; Collin J Weber; Noel M Ziebarth; Peter Buchwald; Alice A Tomei
Journal:  Front Bioeng Biotechnol       Date:  2022-05-16

2.  Longitudinal serological measures of common infection in the Avon Longitudinal Study of Parents and Children cohort.

Authors:  Ruth E Mitchell; Hannah J Jones; Robert H Yolken; Glen Ford; Lorraine Jones-Brando; Susan M Ring; Alix Groom; Sophie FitzGibbon; George Davey Smith; Nicholas J Timpson
Journal:  Wellcome Open Res       Date:  2018-07-23

3.  Smoke exposure and cardio-metabolic profile in youth with type 1 diabetes.

Authors:  Valeria Calcaterra; Jonathan P Winickoff; Catherine Klersy; Luca Maria Schiano; Rossella Bazzano; Chiara Montalbano; Valeria Musella; Corrado Regalbuto; Daniela Larizza; Hellas Cena
Journal:  Diabetol Metab Syndr       Date:  2018-07-06       Impact factor: 3.320

4.  Recovery of Cardiac Remodeling and Dysmetabolism by Pancreatic Islet Injury Improvement in Diabetic Rats after Yacon Leaf Extract Treatment.

Authors:  Klinsmann Carolo Dos Santos; Sarah Santiloni Cury; Ana Paula Costa Rodrigues Ferraz; José Eduardo Corrente; Bianca Mariani Gonçalves; Luiz Henrique de Araújo Machado; Robson Francisco Carvalho; Ana Cláudia de Melo Stevanato Nakamune; Alexandre Todorovic Fabro; Paula Paccielli Freire; Camila Renata Corrêa
Journal:  Oxid Med Cell Longev       Date:  2018-04-10       Impact factor: 6.543

5.  The basal to total insulin ratio in outpatients with diabetes on basal-bolus regimen.

Authors:  Elena Castellano; R Attanasio; V A Giagulli; A Boriano; M Terzolo; E Papini; E Guastamacchia; S Monti; A Aglialoro; D Agrimi; E Ansaldi; A C Babini; A Blatto; D Brancato; C Casile; S Cassibba; C Crescenti; M L De Feo; A Del Prete; O Disoteo; F Ermetici; V Fiore; A Fusco; D Gioia; A Grassi; D Gullo; F Lo Pomo; A Miceli; M Nizzoli; M Pellegrino; B Pirali; C Santini; S Settembrini; E Tortato; V Triggiani; A Vacirca; G Borretta
Journal:  J Diabetes Metab Disord       Date:  2018-10-01

6.  Impaired Gastric Hormone Regulation of Osteoblasts and Lysyl Oxidase Drives Bone Disease in Diabetes Mellitus.

Authors:  Eileen J Daley; Paola Divieti Pajevic; Sayon Roy; Philip C Trackman
Journal:  JBMR Plus       Date:  2019-08-07

7.  Exosomes Secreted by Umbilical Cord Blood-Derived Mesenchymal Stem Cell Attenuate Diabetes in Mice.

Authors:  Rajni Sharma; Manju Kumari; Suman Mishra; Dharmendra K Chaudhary; Alok Kumar; Batia Avni; Swasti Tiwari
Journal:  J Diabetes Res       Date:  2021-12-10       Impact factor: 4.011

8.  Renoprotective Effect of Ocimum Basilicum (Basil) Against Diabetes-induced Renal Affection in Albino Rats.

Authors:  Daklallah Ahmed Almalki
Journal:  Mater Sociomed       Date:  2019-12

9.  Evaluation of the Central Effects of Systemic Lentiviral-Mediated Leptin Delivery in Streptozotocin-Induced Diabetic Rats.

Authors:  Kimberly A Clark; Andrew C Shin; Madhu P Sirivelu; Ramya C MohanKumar; Sreenivasa R Maddineni; Ramesh Ramachandran; Puliyur S MohanKumar; Sheba M J MohanKumar
Journal:  Int J Mol Sci       Date:  2021-12-07       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.